Rockwell Medical regains Nasdaq compliance for minimum bid price

Rockwell Medical, Inc. (Nasdaq: RMTI), a hemodialysis products company based in Wixom, Mich., announced it has received notice from Nasdaq that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).

According to a press release, the company's shares maintained a closing bid price of at least $1.00 per share from July 1, 2026 to July 15, 2026, satisfying the requirement. Nasdaq has closed the matter as a result.

Rockwell Medical stated it is now in full compliance with all Nasdaq continued listing requirements, and its stock remains listed and traded on the Nasdaq Capital Market under the ticker symbol "RMTI."

You May Also Be Interested In

• Securitize Corp (SECZ) PT Raised to $12 at StoneX on 'Innovation Exemption'
• Recon Technology regains Nasdaq minimum bid price compliance
• Saratoga Investment CFO steps down for health reasons, replacements named